- FOUNDED 2007
Overview
The Cancer Genetics Group provides a national forum for discussion and interaction among clinical, research and support service personnel engaged in cancer genetics research, treatment and management.
Originally established as the Familial Cancer Group within COSA, the Group merged with the Human Genetics Society of Australasia (HGSA) Cancer Genetics Special Interest Group in 2020.
The Group is represented by an Executive Committee with interest in the germline and somatic aspects of cancer genetics.
Membership includes a broad range of professionals, including: Clinical Geneticists, Genetic Counsellors, Oncologists, Scientists, Researchers and others who have an interest in cancer genetics across Australasia.
Some of the issues in which the Group has interest include:
- supporting continuing education of cancer health care professionals on relevant cancer genetics topics
- facilitating networks within familial and/or somatic cancer genetics communities in Australia to accelerate the translation of genetic discoveries into meaningful improvements in care pathways and outcomes for patients
- development of consistent clinical protocols across Australia
- advocacy on issues related to cancer genetics
The Group holds professional development days and webinars, and contributes to various scientific meetings.
Group information
COSA and HGSA Cancer Genetics Group Terms of Reference – Council approved 16 October 2020
What’s the latest
Group Chair
Group Chair
Simon Troth
Cancer Genetics Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 24 days ago
Read the latest news from COSA and COSA members in our January eNews. Check your inbox or login to your COSA member account to view now: bit.ly/3E9PrHm
Read More >
COSAoncology one month ago
Cancer Survivorship 2025 will showcase innovation in survivorship care, research, advocacy and policy. Health professionals and public are encouraged to attend. Earlybird registration closes this Friday 17 January. View the program and register at bit.ly/3sai0LG #Surv25
Read More >
COSAoncology 2 months ago
RT by @cosaoncology: Disability and cancer care – We can do both! - @ShonaEdwards2 @CVSAinfo @COSAoncology oncodaily.com/blog/198335 #Cancer #CancerCare #DisabilityCare #MedX #MedNews #Health #Medicine #OncoDaily #Oncology
Read More >
COSAoncology 2 months ago
RT by @cosaoncology: Great to see how research has expanded in #AYA psychosocial care 🙌🏻 Dr Ursula Sansom-Daly @usansomdaly presents the updated, evidence-based @COSAoncology Guidelines for the Psychosocial Management of AYAs with #cancer - coming soon! Learn more: cosa.org.au/about/projects… #AYACSM
Read More >
COSAoncology 2 months ago
Read the latest news from COSA and COSA members in our November eNewsletter. Check your inbox or login to your COSA member account to view now: bit.ly/4cI0nc3
Read More >
COSAoncology 2 months ago
Congratulations David Thomas for recognition of your leadership and groundbreaking work in genomics in cancer care. And congratulations to all the recipients of the 2024 Premier's Awards for Outstanding Cancer Research. #cancerNSWawards
Read More >
COSAoncology 2 months ago
Congratulations Ashfaq Chauhan for recognition of your work to enhance cancer care for people from CALD backgrounds.
Read More >
COSAoncology 2 months ago
Congratulations @DrNicolasHart for recognition of your work to improve outcomes of all people affected by cancer.
Read More >
COSAoncology 2 months ago
Congratulations @yapml for recognition of your important work in equity and cancer care.
Read More >
COSAoncology 3 months ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 in Melbourne, 6-7 March. We particularly welcome submissions from survivors themselves and those whose work is in partnership with survivors bit.ly/3E92y9j
Read More >